ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 1 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,342,000 | -19.0% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,891,000 | -9.6% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,199,000 | -49.0% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,278,000 | -45.1% | 11,206 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $11,430,000 | -25.0% | 11,206 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $15,240,000 | -20.0% | 11,206 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $19,050,000 | +37.1% | 11,206 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $13,895,000 | -12.7% | 11,206 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $15,913,000 | +17.4% | 11,206 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $13,559,000 | +17.5% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $11,542,000 | -39.1% | 11,206 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $18,938,000 | – | 11,206 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Values First Advisors, Inc. | 250,110 | $528,000 | 0.51% |
| XTX MARKETS LLC | 12,925 | $27,000 | 0.19% |
| Cornerstone Capital, Inc. | 491,560 | $1,037,000 | 0.15% |
| Aristides Capital LLC | 64,482 | $136,000 | 0.10% |
| LINCOLN CAPITAL CORP | 57,000 | $120,000 | 0.09% |
| HighVista Strategies LLC | 41,400 | $87,000 | 0.07% |
| Ahrens Investment Partners LLC | 61,500 | $130,000 | 0.05% |
| J Arnold Wealth Management Co | 18,000 | $38,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 114,437 | $241,000 | 0.03% |
| Avidian Wealth Solutions, LLC | 63,000 | $133,000 | 0.02% |